NCT06080945View on ClinicalTrials.gov

Tailored Pharmacist-led Intervention to Improve Adherence to Budesonide

NARecruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

November 8, 2023

Study Completion Date

June 30, 2024

Conditions
Asthma in Children
Interventions
OTHER

pharmacist-led patient-centered medication therapy management

The intervention group will receive a pharmacist-driven discharge counseling on budesonide, an inhaled glucocorticoid, from recruitment, until 12 months.

Trial Locations (1)

312000

RECRUITING

Shaoxing Maternity and Child Care hospital, Shaoxing

All Listed Sponsors
lead

Shaoxing Maternity and Child Health Care Hospital

OTHER